Status:
COMPLETED
Retrospective Multicentre Observational Study on the Incidence of Hyperoxia in Non-intubated Patients in Intensive Care in Belgium Study OxSIZgen
Lead Sponsor:
SIZ Nursing
Conditions:
Hyperoxia
Eligibility:
All Genders
18+ years
Brief Summary
Oxygen is the most widely prescribed therapy in the ICU (intensive care unit) and can save lives in critical patients. While the deleterious effects of hypoxia are apparent and must be actively avoide...
Eligibility Criteria
Inclusion
- Patient having oxygen
- Not to be ventilated
- Being over 18 years old
Exclusion
- Sickle cell disease patient
- Patient with pneumo/hemothorax
- Pregnant women, prisoners, denial of informed consent
- Patients who are related to an investigator
- Patients undergoing hyperbaric chamber therapy
- Patients with CO
- Patients on ECMO
- Patients with paracoate poisoning...
- Patients included in other interventional studies
Key Trial Info
Start Date :
September 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 25 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04291911
Start Date
September 21 2020
End Date
September 25 2020
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bruyneel Arnaud
La Louvière, Belgium